Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Single-dose of Ciprofloxacin prophylaxis

PreclinicalSmall molecule

Single-dose of Ciprofloxacin prophylaxis is one of 2 small molecule programs targeting Retrograde Intrarenal Surgery. It is currently in Preclinical.

1

Indications

1

Total Trials

0

Active Trials

1

Competitors

Pipeline

Status by Indication[3][1]

Indication

Retrograde Intrarenal SurgeryUnknown status

Retrograde Intrarenal SurgeryPreclinical

Unknown status

Competition

Competitive Landscape

2 competitors in Retrograde Intrarenal Surgery

#DrugCompanyPhaseTrials

Levaquin

Single-dose of Ciprofloxacin prophylaxis

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Retrograde Intrarenal Surgery1 trial

Comparison of Multiple-, Single- and Zero-dose of Ciprofloxacin Prophylaxis in Retrograde Intrarenal Surgery

Unknown status·GGuohua Zeng·N/A·NCT02304822·450 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Single-dose of Ciprofloxacin prophylaxis. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Single-dose of Ciprofloxacin prophylaxis compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Single-dose of Ciprofloxacin prophylaxis. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Guohua Zeng company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: GGuohua Zeng

Related News